|
| | 
|
 | |
        
|  |
 
|
 SANOFI - [Ticker: SAN.PA] |     | | Last Trade | 80.53 | Last Trade Time | 2017-11-01 - 21:36:00 | | Variation | -0.76 (-0.93%) | Open | 81.79 | | High | 81.99 | Low | 80.43 | | Volume | 2,902,429 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 71.12 x 1,000 - 71.74 x 44,000 | | Former Close | 81.29 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about SANOFI: | | No topics about SANOFI [SAN.PA] have been found, but a search on the Forum for more topics related to SANOFI is advised. |
|
News about SANOFI [SAN.PA]: (ordered by relevance)
| | Seagen goes to Pfizer for $43B; Sanofi buys diabetes partner ... Endpoints News
Sanofi to cut US price of its most-prescribed insulin by 78% Reuters
Facing political pressure, Sanofi follows Eli Lilly and Novo Nordisk in slashing insulin prices CNBC
Another one! Sanofi joins growing list of insulin manufacturers to cap cost of life-saving drug Daily Mail
Sanofi to acquire Provention Bio in deal worth $2.9bn PMLiVE
Ipsen receives new palovarotene PDUFA date; Acer halts ... Endpoints News
Sanofi adds mRNA 2.0 to its vaccine toolkit KBR
Sanofi reports positive new data for multiple sclerosis treatment ... PMLiVE
Sanofi's site modernization spree rolls on with plan to shift 2000 ... FiercePharma
Sanofi and Sobi?s once-weekly haemophilia A treatment approved ... PMLiVE
Sanofi - Aventis Groupe Announcements | Sanofi - Aventis Groupe ... InvestEgate
Sanofi (SNY) Dips More Than Broader Markets: What You Should ... Yahoo Finance
Patent wars: What?s behind Amgen?s possible win over Sanofi at the ... Pharmaceutical Technology
Investors in Sanofi (EPA:SAN) have made a decent return of 66% over the past five years Simply Wall St
Sanofi Could Be on a Roll With a Strong Performance and Its Latest ... The Motley Fool
Lilly Slashed Its Insulin Prices. Will Sanofi and Novo Nordisk Do the ... Managed Healthcare Executive
The IIIs have it! Sanofi's fresh approval of bleeding drug Altuviiio ... FiercePharma
Bernie Sanders calls out Sanofi, Novo Nordisk for insulin prices FiercePharma
Glooko, Sanofi announce partnership to support diabetes patients Medical Device Network
Sanofi: Phase-3 study on Hemophilia A treatment met primary ... Reuters
Successful transaction: Adragos Pharma has officially taken over the ... RealWire
Regeneron, Sanofi's Kevzara nabs polymyalgia rheumatica FDA nod FiercePharma
Sanofi to discontinue Insuman® insulins over upcoming months DiabetesTimes.co.uk
Sanofi invests in successful Geisinger Commonwealth REACH-HEI ... Geisinger
Sanofi India declares ?194 final dividend and ?183 special dividend | Mint Mint
Shaheen, Collins Issue Joint Statement on Sanofi?s Decision to ... Senator Jeanne Shaheen
Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi Yahoo Finance
Rabies Vaccine Market Generated Opportunities, Future Scope ... Digital Journal
Morristown council breaks more Sanofi news, and questions ... Morristown Green
Sanofi, Regeneron launch new Dupixent asthma TV ad urging ... FiercePharma
Human Combination Vaccines Market Future Business ... Digital Journal
Sanofi Stock: Pharma Tees Up To Rival Pfizer In RSV Vaccine Battle ... Investor's Business Daily
Drug developer QurAlis raises $88 mln in Sanofi-backed funding ... Reuters.com
Recon: FDA approves Sanofi's bleeding disorder drug; Sen. Warren ... Regulatory Focus
Sepsis - Pipeline Insight, 2022: Innovations from SciClone, Sanofi ... businesswire.com
Sanofi sings a song for rare disease and equitable care pharmaphorum
Sanofi to bring two rare disease therapies to India BusinessLine
Mayor Touts M Station Addition As Sanofi Prepares For Morristown Move Patch
Sanofi plans to cut price of insulin, following Eli Lilly, Novo Nordisk WUSA9.com
public companies who own 60% along with institutions invested in Sanofi India Limited (NSE:SANOFI) saw increase in their holdings value last week Simply Wall St
CDSCO Panel grants Sanofi's Protocol Amendment Proposal for Quadrivalent Meningococcal Conjugate Vaccine Medical Dialogues
Zacks.com featured highlights Sanofi, SK Telecom, PBF Energy, Arrow Electronics and Novartis Yahoo Finance
Amgen Reply Brief Addresses Mischaracterizations by Sanofi, U.S. ... IPWatchdog.com
Despite Boston layoffs, business is booming: Resilience CEO FiercePharma
Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review Nasdaq
Buy Sanofi India, target price Rs 6200: Sharekhan by BNP Paribas The Economic Times
Acer Therapeutics' Product Acquired From Sanofi Fails In Menopause Study - Acer Therapeutics (NASDAQ:ACER Benzinga
Global RNAi Therapeutics Market 2023 to 2027: Featuring Sanofi, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma and Sirnaomics Yahoo Finance
Amgen v. Sanofi: Supreme Court to Hear Patent Enablement ... Lexology
A Look Into Sanofi's Debt - Sanofi (NASDAQ:SNY) Benzinga
Sanofi's Buscopan combines high fashion with IBS awareness at ... MM+M Online
Pfizer's maternal RSV vaccine filing gets priority review, setting up ... FierceBiotech
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing? Marketscreener.com
Lysosomal Storage Diseases Therapeutics Market Is Expected To ... Digital Journal
Dividend Stocks: These 2 companies announce 3900% dividend to shareholders Zee Business
North America Kidney Transplant Market Report 2023 - 2027 ... businesswire.com
Global Endometriosis Market Report 2023: Featuring Teva, Sun ... Yahoo Finance
Sanofi?s enzyme replacement therapy available on NHS to Pompe ... PMLiVE
Sanofi Pasteur COVID-19 vaccine authorised by MHRA GOV.UK
GSK and Sanofi shares surge after Zantac ruling victory Financial Times
Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi ... GOV.UK
Sanofi trade union network building constructive relationship with ... IndustriALL Global Union
UK at risk of losing healthcare innovation race with European rivals ... Financial Times
Signed order Sanofi International Biotech Company Ltd. GOV.UK
Sanofi: The arrival of the 'haute couture' supply chain Supply Chain Digital
Decision on Sanofi Ltd GOV.UK
Sanofi announces change in R&D leadership Science Business
Sanofi and Innate Pharma expand cancer therapeutics collaboration PMLiVE
Is Sanofi's Stock Performance Being Led By Robust Fundamentals? Simply Wall St
Sanofi and Regeneron face a high-risk test for Dupixent evaluate.com
Decision on Sanofi International Biotech Company Ltd. GOV.UK
Sanofi/Regeneron?s Dupixent approved by EC for eosinophilic ... PMLiVE
Sanofi CFO says stock price pummelling grossly overdone Reuters
Exclusive: Sanofi to let go of staff at vaccine plants in India as part of ... Reuters.com
Sanofi started?and lost?$28B bidding war for Horizon. Is the ... FiercePharma
Big Pharma divided? Pfizer, AZ, Lilly and more support Sanofi in ... FiercePharma
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up FierceBiotech
JPM23: Sanofi has reached the 'steady state' Paul Hudson ... FiercePharma
Sanofi offers refunds for Cablivi in novel model for rebates Pharmaceutical Technology
Sanofi/ Regeneron?s Dupixent recommended by CHMP to treat ... PMLiVE
Sanofi forecasts moderate profit growth on Dupixent demand Reuters
Sanofi enlists Thread as decentralised clinical trial provider in new ... Clinical Trials Arena
AstraZeneca, Sanofi tee up 3-way RSV battle in 2023 as FDA ... FiercePharma
Surprise, Skepticism And Scorn: Reaction To Rumored Haleon ... HBW Insight
GSK, Sanofi, Takeda sign with Singapore partnership to advance ... FiercePharma
Bruised by high profile cancer setbacks, Sanofi CEO plots early ... FierceBiotech
GSK takes a cue from Sanofi with plans for a new headquarters FiercePharma
Sanofi and Regeneron?s Dupixent granted EC approval for prurigo ... PMLiVE
Sanofi to sell Japanese manufacturing plant European Pharmaceutical Review
Amgen, J&J and Sanofi size up Horizon as Big Pharma renews ... FiercePharma
Euro Q4 Consumer Health Earnings Preview: Sanofi, Bayer, Reckitt ... HBW Insight
Sanofi seeks to launch blood disorder drug this year, CNBC reports Reuters
Sanofi picks Thread as sole provider of decentralized clinical trials ... OutSourcing-Pharma.com
Sanofi's (EPA:SAN) 6.3% CAGR outpaced the company's earnings growth over the same five-year period Simply Wall St
Sanofi, Boehringer expect answers in Zantac dispute this year FiercePharma
Sanofi's market cap is in free fall, but the reaction is 'overdone ... FiercePharma
Is Sanofi A Buy, Despite Recent Stumbles? Entrepreneur
J&J bows out of Horizon bid as Sanofi and Amgen eye cash plays FiercePharma
Sanofi and GSK?s next-generation COVID-19 booster vaccine ... GSK
| For more news about SANOFI click here:
SANOFI News |
|
Website Width:
Background image: |
|  | |
|
|
![SANOFI - [Ticker: SAN.PA] chart](http://www.tr4der.com/chart/tr4der-SAN.PA-1-month.png)
